vs

Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and Mastech Digital, Inc. (MHH). Click either name above to swap in a different company.

Mastech Digital, Inc. is the larger business by last-quarter revenue ($45.5M vs $38.3M, roughly 1.2× ImmunityBio, Inc.). Mastech Digital, Inc. runs the higher net margin — 2.1% vs -161.8%, a 163.9% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs -10.4%). Mastech Digital, Inc. produced more free cash flow last quarter ($4.3M vs $-71.3M).

ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

IBRX vs MHH — Head-to-Head

Bigger by revenue
MHH
MHH
1.2× larger
MHH
$45.5M
$38.3M
IBRX
Growing faster (revenue YoY)
IBRX
IBRX
+417.4% gap
IBRX
407.0%
-10.4%
MHH
Higher net margin
MHH
MHH
163.9% more per $
MHH
2.1%
-161.8%
IBRX
More free cash flow
MHH
MHH
$75.6M more FCF
MHH
$4.3M
$-71.3M
IBRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IBRX
IBRX
MHH
MHH
Revenue
$38.3M
$45.5M
Net Profit
$-61.9M
$972.0K
Gross Margin
99.0%
28.3%
Operating Margin
-169.0%
2.2%
Net Margin
-161.8%
2.1%
Revenue YoY
407.0%
-10.4%
Net Profit YoY
-4.7%
227.3%
EPS (diluted)
$-0.06
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IBRX
IBRX
MHH
MHH
Q4 25
$38.3M
$45.5M
Q3 25
$32.1M
$48.5M
Q2 25
$26.4M
$49.1M
Q1 25
$16.5M
$48.3M
Q4 24
$7.6M
$50.7M
Q3 24
$6.1M
$51.8M
Q2 24
$49.5M
Q1 24
$46.8M
Net Profit
IBRX
IBRX
MHH
MHH
Q4 25
$-61.9M
$972.0K
Q3 25
$-67.3M
$941.0K
Q2 25
$-92.6M
$135.0K
Q1 25
$-129.6M
$-1.4M
Q4 24
$-59.2M
$297.0K
Q3 24
$-85.7M
$1.9M
Q2 24
$1.4M
Q1 24
$-161.0K
Gross Margin
IBRX
IBRX
MHH
MHH
Q4 25
99.0%
28.3%
Q3 25
99.4%
27.8%
Q2 25
99.5%
28.1%
Q1 25
99.6%
26.7%
Q4 24
29.0%
Q3 24
28.5%
Q2 24
28.2%
Q1 24
25.9%
Operating Margin
IBRX
IBRX
MHH
MHH
Q4 25
-169.0%
2.2%
Q3 25
-173.5%
1.7%
Q2 25
-269.8%
0.1%
Q1 25
-390.1%
-3.8%
Q4 24
-919.0%
0.1%
Q3 24
-1314.3%
4.7%
Q2 24
3.4%
Q1 24
-0.9%
Net Margin
IBRX
IBRX
MHH
MHH
Q4 25
-161.8%
2.1%
Q3 25
-209.8%
1.9%
Q2 25
-350.3%
0.3%
Q1 25
-784.9%
-3.0%
Q4 24
-783.4%
0.6%
Q3 24
-1404.0%
3.6%
Q2 24
2.8%
Q1 24
-0.3%
EPS (diluted)
IBRX
IBRX
MHH
MHH
Q4 25
$-0.06
$0.08
Q3 25
$-0.07
$0.08
Q2 25
$-0.10
$0.01
Q1 25
$-0.15
$-0.12
Q4 24
$-0.08
$0.01
Q3 24
$-0.14
$0.16
Q2 24
$0.12
Q1 24
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IBRX
IBRX
MHH
MHH
Cash + ST InvestmentsLiquidity on hand
$242.8M
$36.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$-500.5M
$89.3M
Total Assets
$501.9M
$111.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IBRX
IBRX
MHH
MHH
Q4 25
$242.8M
$36.5M
Q3 25
$257.8M
$32.7M
Q2 25
$153.7M
$27.9M
Q1 25
$61.6M
$24.7M
Q4 24
$149.8M
$27.7M
Q3 24
$130.4M
$23.9M
Q2 24
$20.6M
Q1 24
$19.4M
Stockholders' Equity
IBRX
IBRX
MHH
MHH
Q4 25
$-500.5M
$89.3M
Q3 25
$-524.3M
$88.0M
Q2 25
$-570.7M
$87.8M
Q1 25
$-591.4M
$86.9M
Q4 24
$-489.1M
$87.4M
Q3 24
$-745.1M
$86.5M
Q2 24
$84.0M
Q1 24
$81.7M
Total Assets
IBRX
IBRX
MHH
MHH
Q4 25
$501.9M
$111.8M
Q3 25
$519.0M
$112.6M
Q2 25
$402.1M
$110.4M
Q1 25
$303.8M
$110.1M
Q4 24
$382.9M
$111.5M
Q3 24
$364.6M
$111.5M
Q2 24
$107.5M
Q1 24
$106.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IBRX
IBRX
MHH
MHH
Operating Cash FlowLast quarter
$-70.4M
$4.4M
Free Cash FlowOCF − Capex
$-71.3M
$4.3M
FCF MarginFCF / Revenue
-186.2%
9.5%
Capex IntensityCapex / Revenue
2.4%
0.1%
Cash ConversionOCF / Net Profit
4.48×
TTM Free Cash FlowTrailing 4 quarters
$-308.8M
$10.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IBRX
IBRX
MHH
MHH
Q4 25
$-70.4M
$4.4M
Q3 25
$-68.9M
$6.5M
Q2 25
$-79.7M
$3.3M
Q1 25
$-85.9M
$-3.0M
Q4 24
$-85.1M
$4.0M
Q3 24
$-98.8M
$3.3M
Q2 24
$1.2M
Q1 24
$-1.3M
Free Cash Flow
IBRX
IBRX
MHH
MHH
Q4 25
$-71.3M
$4.3M
Q3 25
$-69.6M
$6.3M
Q2 25
$-80.8M
$3.2M
Q1 25
$-87.0M
$-3.1M
Q4 24
$-87.3M
$3.9M
Q3 24
$-101.6M
$3.2M
Q2 24
$707.0K
Q1 24
$-1.6M
FCF Margin
IBRX
IBRX
MHH
MHH
Q4 25
-186.2%
9.5%
Q3 25
-217.2%
13.0%
Q2 25
-305.9%
6.6%
Q1 25
-526.9%
-6.4%
Q4 24
-1155.4%
7.7%
Q3 24
-1663.2%
6.2%
Q2 24
1.4%
Q1 24
-3.4%
Capex Intensity
IBRX
IBRX
MHH
MHH
Q4 25
2.4%
0.1%
Q3 25
2.3%
0.4%
Q2 25
4.1%
0.1%
Q1 25
6.8%
0.2%
Q4 24
28.0%
0.2%
Q3 24
45.7%
0.1%
Q2 24
1.0%
Q1 24
0.6%
Cash Conversion
IBRX
IBRX
MHH
MHH
Q4 25
4.48×
Q3 25
6.88×
Q2 25
24.41×
Q1 25
Q4 24
13.60×
Q3 24
1.76×
Q2 24
0.85×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IBRX
IBRX

Segment breakdown not available.

MHH
MHH

IT Staffing Services$37.6M83%
Data And Analytics Services$7.8M17%

Related Comparisons